Obesema 0.25mg Injection
Dosage
Starting at just
$63.53
In stock
Only %1 left
SKU
CMS9010
What is Obesema 0.25 mg Injection
Obesema 0.25 mg Injection is a chronic weight management and anti-diabetic medicine. It contains Semaglutide base, a Food and Drug Administration (FDA)-approved Glucagon-Like Peptide-1 (GLP-1) receptor agonist. The Obesema 0.25 mg pre-filled pen delivers a precise, once-weekly Semaglutide injection under the skin. Each pen contains four doses for monthly use.
Obesema 0.25 mg Injection is manufactured by Alkem Laboratories. The salts in this medication are FDA-approved, and this medicine is produced in a Good Manufacturing Practice (GMP)-compliant, World Health Organization (WHO)-approved facility. This ensures consistent quality, accurate dose delivery, and safety with every injection.
Obesema 0.25 mg Injection uses include supporting Obesity treatment and managing Type 2 Diabetes Mellitus (T2DM) alongside diet and exercise. Semaglutide mimics GLP-1, a hormone the body releases after eating. It helps individuals feel less hungry, slows stomach emptying, boosts insulin release when blood sugar is high, and reduces glucagon so the liver releases less glucose. This dual action supports both blood sugar control and appetite control.
The recommended dosage of Obesema 0.25 mg Injection is 1 injection per week. The initial dose of 0.25 mg subcutaneously once weekly for four weeks is intended for treatment initiation. A doctor will then adjust the dose based on individual response and treatment goals. Always follow the doctor's instructions for the Obesema 0.25 mg Injection dosage.
The appetite control medicine injection is given in the thigh, abdomen, or upper arm, and this weight-loss injection may be used with or without meals. If a Semaglutide dose is missed, administer it as soon as possible within five days. If more than five days have passed, skip the missed injection and resume the regular weekly schedule.
Common Obesema 0.25 mg Injection side effects include nausea, vomiting, diarrhea, constipation, and Semaglutide injection site reactions. Nausea usually lessens as the body continues to adjust to Semaglutide. Contact a doctor promptly if side effects persist or worsen.
Individuals with a personal or family history of medullary thyroid carcinoma or known hypersensitivity to Semaglutide should not use this medicine. Always ask a doctor before starting or stopping this medicine, especially if taking Insulin or other Diabetes medications.
Store Obesema 0.25 mg Injection in the refrigerator between 36°F and 46°F (2°C and 8°C). Protect it from light and do not freeze. After first use, follow the storage instructions provided with the pen. Keep out of reach of children.
What are the benefits of taking Obesema 0.25 mg Injection
Obesema 0.25 mg Injection offers multiple clinically supported benefits through its active salt, Semaglutide, a GLP-1 receptor agonist. Semaglutide stimulates the pancreas to release insulin and lowers the hunger hormone ghrelin, thereby decreasing appetite and slowing stomach emptying. This mechanism supports both chronic weight management and blood sugar control. Key benefits include:
- Obesity treatment and weight loss: This weight-loss injection helps individuals who are obese or overweight with weight-related medical conditions when used alongside diet and exercise.
- Blood sugar control: It manages blood sugar in individuals having Type 2 Diabetes Mellitus (T2DM) by enabling the pancreas to release the appropriate amount of insulin when blood sugar is high.
- Kidney protection: Semaglutide can also protect the kidneys from damage caused by high blood sugar levels, which can cause Chronic Kidney Disease and kidney failure.
- Cardiovascular protection: Clinical trials have found that Semaglutide decreases the chances of major cardiovascular events, including heart attack and stroke, in people who are overweight or obese who have known cardiovascular disease.
How to take Obesema 0.25 mg Injection
Obesema 0.25 mg Injection is a doctor-supervised Semaglutide injection that should be taken strictly as directed by a doctor. This injection is not meant for self-administration. It should always be administered by an expert healthcare provider.
Always consult a doctor before starting or modifying the Obesema 0.25 mg Injection dosage for safe and effective chronic weight management or Diabetes care.
Here are general usage guidelines:
- Obesema 0.25 mg Injection is usually administered once weekly, on the same day each week, at a time as advised by the treating doctor.
- The site of administration should be decided and handled by a trained medical professional. It is usually injected under the skin of the thigh, abdomen, or upper arm.
- The medicine may be given with or without food, depending on the doctor’s instructions.
- If a schedule change is needed, it should be done only under a doctor’s guidance.
- Your healthcare provider will manage the injection site and all related procedures, such as rotating injection sites, to ensure safety and minimize the risk of skin irritation.
Strengths and Substitutes
Currently, Obesema is only available as a 0.25 mg Semaglutide injection. However, Cheap Medicine Shop offers a range of Semaglutide-based products as suitable alternatives, including both injectable and oral options to support different stages of chronic weight management and Diabetes treatment. Always consult a doctor before switching between strengths or formulations.
| Wegovy 0.25 mg | $270.58/injection |
| Wegovy 0.5 mg | $270.58/injection |
| Wegovy 1 mg | $270.58/injection |
| Wegovy 1.7 mg | $378.77/injection |
What are the side effects of Obesema 0.25 mg Injection
Like any medication, Obesema 0.25 mg Injection may cause some side effects. Most are temporary and subside as the body adjusts to Semaglutide. Consult a doctor if they last or worsen:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Injection site redness or itching
- Tiredness
Safety Advice
Liver Disease
Individuals with liver disease should consult a doctor before using Obesema 0.25 mg Injection. Semaglutide slows stomach emptying, which may affect how other medications are absorbed, placing additional stress on a compromised liver.
Kidney Impairment
Semaglutide is FDA-approved to reduce the risk of Chronic Kidney Disease (CKD) worsening in individuals with Type 2 Diabetes and CKD, and it may be used under medical supervision in this group. However, those experiencing side effects such as nausea, vomiting, or diarrhea should contact a doctor promptly, as dehydration from these effects may temporarily stress kidney function. Always consult a doctor before use.
Pregnant and Breastfeeding women
Obesema 0.25 mg Injection is not safe during pregnancy or breastfeeding. It is recommended to stop use at least two months before a planned pregnancy.
Avoid
Avoid alcohol, as it enhances the risk of low blood sugar. Individuals allergic to Semaglutide or any ingredient in this injection should not use it. Inform a doctor about all current medications, particularly Insulin or Sulfonylureas, as combining them may increase the risk of Low Blood Sugar.
FAQs
What is the recommended dosage of Obesema 0.25 mg Injection?
The starting dose of Obesema 0.25 mg Injection is one injection per week for the first four weeks. A doctor will then adjust the dose based on individual response and treatment goals. Always follow the doctor's instructions and never change the dosage without medical guidance.
What are the common side effects of Obesema 0.25 mg Injection?
The most common side effects of Obesema 0.25 mg Injection include nausea, vomiting, diarrhea, constipation, tiredness, and injection site reactions. These effects are usually mild and tend to reduce as the body adjusts to Semaglutide. Consult a doctor if any side effects last or worsen over time.
Is Obesema 0.25 mg Injection safe for long-term use?
Yes, Obesema 0.25 mg is intended for long-term chronic weight management and Diabetes care when used under medical supervision. Clinical trials have displayed that Semaglutide is effective and well-tolerated over extended periods. However, regular doctor check-ins are important for monitoring progress and managing any side effects.
Who should not use Obesema 0.25 mg Injection?
Individuals with a personal or family history of Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or an allergy to Semaglutide should not use this injection. Pregnant or breastfeeding individuals should also avoid it. Always consult a doctor before starting Semaglutide injection.
Can Obesema 0.25 mg Injection be used for Diabetes?
Yes, Obesema injection can be used to manage Type 2 Diabetes Mellitus (T2DM). It helps the pancreas release the right amount of insulin and lowers blood sugar levels when used alongside diet and exercise. It is not suitable for Type 1 Diabetes; always consult a doctor first.
How quickly does Obesema 0.25 injection show results?
Blood sugar levels can begin to improve within the first week of starting Obesema injection. Noticeable weight-loss results may take several weeks to months as the dose increases gradually. Individual results vary depending on diet, activity level, and overall health. A doctor can guide on what to expect.
Can Obesema be self-injected at home?
Yes, Obesema injection can be self-administered at home using the pre-filled pen. A doctor or nurse will provide full instructions on how to inject it correctly. Always clean the injection site beforehand, rotate injection areas with each dose, and never share the pen with anyone else.
What's this?
Check "Remember Me" to access your shopping cart on this computer even if you are not signed in.